Reuters logo
in 5 months
BRIEF-Voyager Therapeutics announces lead clinical candidate selection
February 13, 2017 / 12:23 PM / in 5 months

BRIEF-Voyager Therapeutics announces lead clinical candidate selection

1 Min Read

Feb 13 (Reuters) - Voyager Therapeutics Inc :

* Voyager Therapeutics announces lead clinical candidate selection for monogenic form of amyotrophic lateral sclerosis (ALS)

* Voyager Therapeutics-preclinical studies now underway to support filing of an investigational new drug application for VY-SOD101 during Q4 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below